1 completed, 1 not yet recruiting, 1 recruiting, 1 withdrawn. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
Follow crisaborole: new trials by email Literature Review of crisaborole trials Research Report on crisaborole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis. Crisaborole 2% topical ointment, tacrolimus ointment 0.1% - Psoriasis, Psoriasis Genital | Phase 3 | Not yet recruiting | Cairo University | 40 | 2026-10-25 | 2026-10-27 |
| Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study. Crisaborole 2% topical ointment, tacrolimus 0.1%, Excimer Light therapy - Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 3 | Recruiting | Cairo University | 35 | 2026-05-15 | 2026-10-29 |
| Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis JW-100, Eucrisa - Atopic Dermatitis | Phase 3 | Withdrawn | Applied Biology, Inc. | 2022-11-24 | 2022-12-19 | |
| ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis Crisaborole, Tacrolimus 0.03% Ointment - Atopic Dermatitis | Phase 3 | Completed | University of Rochester | 92 | 2019-02-20 | 2022-10-31 |
Dermatitis, Atopic (2) · Psoriasis (1) · Vitiligo (1)
Cairo University (2) · Applied Biology, Inc. (1) · University of Rochester (1)
Egypt (2) · Brazil (1) · United States (1)
Daniel Fonseca, MD (1) · Julie R Wolf, PhD, MPH (1)